PMID: 7037136Jan 1, 1982Paper

Histological identification of prolonged survival of a skin allograft on an extensively burned patient

Burns, Including Thermal Injury
I TakiuchiT Nakajima

Abstract

We applied skin allografts obtained from 38 unrelated volunteers to a very extensively burned female patient. Seven months after skin transplantation, one allograft from a male still survived clinically. In order to ascertain that the graft site resulted from growth of the male donor skin, the allografted area and patient's own unburned normal area were examined by the fluorescent staining of Y-body (Y-chromosomal fluorescence). Y-body was detected in 57 per cent and 65 per cent of cells from the grafted area, whereas no fluorescence was detected in the patient's own unburned normal area. These observations suggest that one allograft from an unrelated donor survived for 221 days on a very extensively burned subject.

References

Feb 1, 1978·Transplantation·J L NinnemannH A Frank
May 1, 1978·The Journal of Investigative Dermatology·G A KornJ H Herndon
Feb 1, 1973·Annals of Surgery·A M MunsterR F Mortensen
Nov 1, 1969·Experimental Cell Research·T CasperssonE Simonsson
Aug 1, 1970·Experimental Cell Research·T CasperssonM Hultén
Mar 22, 1957·Annals of the New York Academy of Sciences·G D KAY
Dec 1, 1962·The Journal of Clinical Investigation·F T RAPAPORTJ H MULHOLLAND

❮ Previous
Next ❯

Citations

Jul 1, 1992·British Journal of Plastic Surgery·J Nanchahal, C M Ward
Jul 1, 1995·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·S A Kolenik, D J Leffell
Oct 1, 1983·Current Problems in Surgery·R G Atnip, J F Burke

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.